PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Sees Large Increase in Short Interest

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) was the target of a large increase in short interest in April. As of April 30th, there was short interest totaling 1,224 shares, an increase of ? from the April 15th total of 0 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 43,884 shares, the short-interest ratio is currently 0.0 days.

PreveCeutical Medical Trading Up 4.3%

OTCMKTS PRVCF traded up $0.00 on Friday, reaching $0.01. 46,000 shares of the stock traded hands. PreveCeutical Medical has a 12 month low of $0.00 and a 12 month high of $0.04. The company has a fifty day moving average price of $0.01 and a 200-day moving average price of $0.02.

PreveCeutical Medical Company Profile

PreveCeutical Medical Inc is a biotechnology company focused on developing non-opioid therapies that target the endocannabinoid system through advanced translational medicine. The company leverages proprietary research in prebiotic and synthetic bioactive compounds to create drug candidates and wellness formulations aimed at addressing metabolic, inflammatory and neurodegenerative disorders. PreveCeutical’s science-driven approach emphasizes collaboration with leading academic institutions to translate laboratory discoveries into therapeutic solutions.

Central to PreveCeutical’s development pipeline is PREV-IX7, a prebiotic drug candidate designed to modulate the gut microbiome for treatment of metabolic syndrome and related endocrine imbalances.